# NCT04470024 (NCT04470024)

> Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04470024
- Phase: PHASE1
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Providence Health & Services
- Conditions: Cancer of the Head and Neck
- Interventions: INCAGN01876; INCMGA00012; DPV-001
- Enrollment: 19
- Primary outcome: Adverse Events Assessment

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- Bluesky threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct04470024